Search alternatives:
mean decrease » a decrease (Expand Search)
nm decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
5 nm » 5 mm (Expand Search), 5 cm (Expand Search)
mean decrease » a decrease (Expand Search)
nm decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
5 nm » 5 mm (Expand Search), 5 cm (Expand Search)
-
241
-
242
Data_Sheet_2_Hepcidin Decreases Rotenone-Induced α-Synuclein Accumulation via Autophagy in SH-SY5Y Cells.ZIP
Published 2020“…We demonstrated that SH-SY5Y cell viability was impaired after rotenone treatment in a dose-dependent manner. α-syn expression and iron content increased under a low concentration rotenone (25 nM for 3 days) treatment in SH-SY5Y cells. …”
-
243
Data_Sheet_1_Hepcidin Decreases Rotenone-Induced α-Synuclein Accumulation via Autophagy in SH-SY5Y Cells.PDF
Published 2020“…We demonstrated that SH-SY5Y cell viability was impaired after rotenone treatment in a dose-dependent manner. α-syn expression and iron content increased under a low concentration rotenone (25 nM for 3 days) treatment in SH-SY5Y cells. …”
-
244
-
245
-
246
-
247
-
248
-
249
-
250
-
251
Regenerating axons are increased by ATRA and decreased by clodronate.
Published 2021“…(E) ATRA and clodronate liposome treatment, composite from 2 sections. Scale bar: 100 μm in A and B. (F) Bar and scatter plots of the number of axons per transverse section, sampled at approximately 200 μm distal to the cut site, showing mean ± SEM. …”
-
252
-
253
Changes in outcome measures after treatment completion in the three groups.
Published 2022Subjects: -
254
-
255
Changes in vital signs (Week4 vs. Week0) after treatment completion within the three groups.
Published 2022Subjects: -
256
-
257
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement.
Published 2022Subjects: -
258
-
259
-
260